Current medical news and unique business news for anyone who cares about the healthcare industry.
Researchers test stinky sock method for malaria prevention. People in three villages in Tanzania have been running experiments to try to trap malaria-infected mosquitoes by using smelly socks to lure them into traps, where they are then poisoned and eventually die. If it works, researchers hope the technique could be used alongside insecticide-treated bed nets as a cost effective way to prevent malaria, which kills almost 900,000 people every year. In previous lab studies, mosquitoes have been attracted to the scent of stinky socks that have been worn by humans.
A handy new device for GPs. DNA Electronics is developing a hand-held device to detect reactions to prescription medicines with just a saliva sample and about 30 minutes.
Inside an Automated Healthcare Practice: Redesigning Care Around People, Not Paperwork
By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.
Negotiations continue for defecit reduction plan. The federal government’s plan for pharmaceutical companies to offer discounts to those with Medicare or Medicaid coverage in order to help reduce the federal defecit is rubbing some in the pharmaceuticals industry the wrong way. Chief executive officer of the Pharmaceutical Research and Manufacturers of America, John Castellani, said Monday that these negotiations could cost the industry $20 billion in revenue and 260,000 job losses.
Biotech stock trades for the second half of 2011. Adam Feuerstein at The Street has put together an interesting look at biotech stock trades for the second half of 2011, based on FDA approvals and drug trials that are likely to wrap up in the next six months.
Durect-Zogenix deal. Durect Corp. and Zogenix Inc. have struck a deal to develop an antipsychotic drug that would top Johnson & Johnson’s schizophrenia treatment Risperdal Consta.